The research was scheduled for presentation Thursday at the annual Alzheimer’s Association worldwide Conference, held from July 18 to 23 in Washington, D.C.
The drugs aim to block the formation of a protein called beta amyloid, which is believed to cause the toxic brain plaques that are considered a hallmark of Alzheimer’s.
“This risk was greatest within a year of receiving antibiotics and increased with the number of antibiotic courses children were prescribed”, said study lead author Dr. Daniel Horton, a research fellow with the Rutgers Biomedical and Health Sciences Child Health...